 | • レポートコード：QAF27569 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の消化性潰瘍治療薬市場について種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、潰瘍保護薬）、用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・消化性潰瘍治療薬市場の概要 ・世界の主要地域別消化性潰瘍治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の消化性潰瘍治療薬市場規模2016-2021：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、潰瘍保護薬） ・世界の消化性潰瘍治療薬市場予測2012-2027：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、潰瘍保護薬） ・世界の消化性潰瘍治療薬市場規模2016-2021：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・世界の消化性潰瘍治療薬市場予測2012-2027：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・消化性潰瘍治療薬のアメリカ市場規模と予測2016-2021 ・消化性潰瘍治療薬のヨーロッパ市場規模と予測2016-2021 ・消化性潰瘍治療薬の中国市場規模と予測2016-2021 ・消化性潰瘍治療薬の日本市場規模と予測2016-2021 ・消化性潰瘍治療薬の東南アジア市場規模と予測2016-2021 ・消化性潰瘍治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、Ask-pharm、Takeda、Yangtze River Pharm、Shandong Luoxin、Huadong Medicine、Changzhou Siyao、Beijing Yuekang、Guangdong Dahua、Xian Janssen） ・消化性潰瘍治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・消化性潰瘍治療薬の市場動向・機会・課題 ・調査の結論 |
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
Market Analysis and Insights: Global Anti-Peptic Ulcer Drugs Market
The global Anti-Peptic Ulcer Drugs market was valued at US$ 8713.4 in 2020 and will reach US$ 18530 million by the end of 2027, growing at a CAGR of 13.4% during 2022-2027.
Global Anti-Peptic Ulcer Drugs Scope and Market Size
The global Anti-Peptic Ulcer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
The Anti-Peptic Ulcer Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Peptic Ulcer Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
1 Anti-Peptic Ulcer Drugs Market Overview
1.1 Anti-Peptic Ulcer Drugs Product Scope
1.2 Anti-Peptic Ulcer Drugs Segment by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Anti-Peptic Ulcer Drugs Segment by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Anti-Peptic Ulcer Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-Peptic Ulcer Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-Peptic Ulcer Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-Peptic Ulcer Drugs Price Trends (2016-2027)
2 Anti-Peptic Ulcer Drugs Estimates and Forecasts by Region
2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-Peptic Ulcer Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-Peptic Ulcer Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
2.4.3 China Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
2.4.6 India Anti-Peptic Ulcer Drugs Estimates and Projections (2016-2027)
3 Global Anti-Peptic Ulcer Drugs Competition Landscape by Players
3.1 Global Top Anti-Peptic Ulcer Drugs Players by Sales (2016-2021)
3.2 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2016-2021)
3.3 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2020)
3.4 Global Anti-Peptic Ulcer Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Anti-Peptic Ulcer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-Peptic Ulcer Drugs Market Size by Type
4.1 Global Anti-Peptic Ulcer Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-Peptic Ulcer Drugs Price by Type (2016-2021)
4.2 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-Peptic Ulcer Drugs Price Forecast by Type (2022-2027)
5 Global Anti-Peptic Ulcer Drugs Market Size by Application
5.1 Global Anti-Peptic Ulcer Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-Peptic Ulcer Drugs Price by Application (2016-2021)
5.2 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-Peptic Ulcer Drugs Price Forecast by Application (2022-2027)
6 North America Anti-Peptic Ulcer Drugs Market Facts & Figures
6.1 North America Anti-Peptic Ulcer Drugs Sales by Company
6.1.1 North America Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
6.1.2 North America Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
6.2 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Type
6.2.1 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Application
6.3.1 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-Peptic Ulcer Drugs Sales Breakdown by Application (2022-2027)
7 Europe Anti-Peptic Ulcer Drugs Market Facts & Figures
7.1 Europe Anti-Peptic Ulcer Drugs Sales by Company
7.1.1 Europe Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
7.1.2 Europe Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
7.2 Europe Anti-Peptic Ulcer Drugs Sales Breakdown by Type
7.2.1 Europe Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-Peptic Ulcer Drugs Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)
8 China Anti-Peptic Ulcer Drugs Market Facts & Figures
8.1 China Anti-Peptic Ulcer Drugs Sales by Company
8.1.1 China Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
8.1.2 China Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
8.2 China Anti-Peptic Ulcer Drugs Sales Breakdown by Type
8.2.1 China Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
8.3 China Anti-Peptic Ulcer Drugs Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Anti-Peptic Ulcer Drugs Market Facts & Figures
9.1 Japan Anti-Peptic Ulcer Drugs Sales by Company
9.1.1 Japan Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
9.1.2 Japan Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
9.2 Japan Anti-Peptic Ulcer Drugs Sales Breakdown by Type
9.2.1 Japan Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-Peptic Ulcer Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anti-Peptic Ulcer Drugs Market Facts & Figures
10.1 Southeast Asia Anti-Peptic Ulcer Drugs Sales by Company
10.1.1 Southeast Asia Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-Peptic Ulcer Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-Peptic Ulcer Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Anti-Peptic Ulcer Drugs Market Facts & Figures
11.1 India Anti-Peptic Ulcer Drugs Sales by Company
11.1.1 India Anti-Peptic Ulcer Drugs Sales by Company (2016-2021)
11.1.2 India Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021)
11.2 India Anti-Peptic Ulcer Drugs Sales Breakdown by Type
11.2.1 India Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-Peptic Ulcer Drugs Sales Breakdown by Type (2022-2027)
11.3 India Anti-Peptic Ulcer Drugs Sales Breakdown by Application
11.3.1 India Anti-Peptic Ulcer Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-Peptic Ulcer Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anti-Peptic Ulcer Drugs Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Ask-pharm
12.2.1 Ask-pharm Corporation Information
12.2.2 Ask-pharm Business Overview
12.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Products Offered
12.2.5 Ask-pharm Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Anti-Peptic Ulcer Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Yangtze River Pharm
12.4.1 Yangtze River Pharm Corporation Information
12.4.2 Yangtze River Pharm Business Overview
12.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Products Offered
12.4.5 Yangtze River Pharm Recent Development
12.5 Shandong Luoxin
12.5.1 Shandong Luoxin Corporation Information
12.5.2 Shandong Luoxin Business Overview
12.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Products Offered
12.5.5 Shandong Luoxin Recent Development
12.6 Huadong Medicine
12.6.1 Huadong Medicine Corporation Information
12.6.2 Huadong Medicine Business Overview
12.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Products Offered
12.6.5 Huadong Medicine Recent Development
12.7 Changzhou Siyao
12.7.1 Changzhou Siyao Corporation Information
12.7.2 Changzhou Siyao Business Overview
12.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Products Offered
12.7.5 Changzhou Siyao Recent Development
12.8 Beijing Yuekang
12.8.1 Beijing Yuekang Corporation Information
12.8.2 Beijing Yuekang Business Overview
12.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Products Offered
12.8.5 Beijing Yuekang Recent Development
12.9 Guangdong Dahua
12.9.1 Guangdong Dahua Corporation Information
12.9.2 Guangdong Dahua Business Overview
12.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Products Offered
12.9.5 Guangdong Dahua Recent Development
12.10 Xian Janssen
12.10.1 Xian Janssen Corporation Information
12.10.2 Xian Janssen Business Overview
12.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Products Offered
12.10.5 Xian Janssen Recent Development
13 Anti-Peptic Ulcer Drugs Manufacturing Cost Analysis
13.1 Anti-Peptic Ulcer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Peptic Ulcer Drugs
13.4 Anti-Peptic Ulcer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Peptic Ulcer Drugs Distributors List
14.3 Anti-Peptic Ulcer Drugs Customers
15 Market Dynamics
15.1 Anti-Peptic Ulcer Drugs Market Trends
15.2 Anti-Peptic Ulcer Drugs Drivers
15.3 Anti-Peptic Ulcer Drugs Market Challenges
15.4 Anti-Peptic Ulcer Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-Peptic Ulcer Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-Peptic Ulcer Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-Peptic Ulcer Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-Peptic Ulcer Drugs Revenue Share by Region (2016-2021)
Table 8. Global Anti-Peptic Ulcer Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Anti-Peptic Ulcer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-Peptic Ulcer Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-Peptic Ulcer Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Anti-Peptic Ulcer Drugs Sales Share by Company (2016-2021)
Table 14. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-Peptic Ulcer Drugs Revenue Share by Company (2016-2021)
Table 16. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2020)
Table 17. Global Anti-Peptic Ulcer Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Anti-Peptic Ulcer Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Peptic Ulcer Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2016-2021)
Table 23. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-Peptic Ulcer Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2022-2027)
Table 26. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2022-2027)
Table 28. Global Anti-Peptic Ulcer Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2016-2021)
Table 31. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-Peptic Ulcer Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2022-2027)
Table 35. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2022-2027)
Table 37. Global Anti-Peptic Ulcer Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 62. China Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 64. China Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 68. China Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 70. China Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 72. China Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 98. India Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Anti-Peptic Ulcer Drugs Sales Market Share by Company (2016-2021)
Table 100. India Anti-Peptic Ulcer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 104. India Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Anti-Peptic Ulcer Drugs Sales Market Share by Type (2022-2027)
Table 106. India Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 108. India Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Anti-Peptic Ulcer Drugs Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. AstraZeneca Anti-Peptic Ulcer Drugs Product
Table 114. AstraZeneca Recent Development
Table 115. Ask-pharm Corporation Information
Table 116. Ask-pharm Description and Business Overview
Table 117. Ask-pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Ask-pharm Anti-Peptic Ulcer Drugs Product
Table 119. Ask-pharm Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Takeda Anti-Peptic Ulcer Drugs Product
Table 124. Takeda Recent Development
Table 125. Yangtze River Pharm Corporation Information
Table 126. Yangtze River Pharm Description and Business Overview
Table 127. Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table 129. Yangtze River Pharm Recent Development
Table 130. Shandong Luoxin Corporation Information
Table 131. Shandong Luoxin Description and Business Overview
Table 132. Shandong Luoxin Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table 134. Shandong Luoxin Recent Development
Table 135. Huadong Medicine Corporation Information
Table 136. Huadong Medicine Description and Business Overview
Table 137. Huadong Medicine Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table 139. Huadong Medicine Recent Development
Table 140. Changzhou Siyao Corporation Information
Table 141. Changzhou Siyao Description and Business Overview
Table 142. Changzhou Siyao Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table 144. Changzhou Siyao Recent Development
Table 145. Beijing Yuekang Corporation Information
Table 146. Beijing Yuekang Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Beijing Yuekang Description and Business Overview
Table 148. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table 149. Beijing Yuekang Recent Development
Table 150. Guangdong Dahua Corporation Information
Table 151. Guangdong Dahua Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Guangdong Dahua Description and Business Overview
Table 153. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table 154. Guangdong Dahua Recent Development
Table 155. Xian Janssen Corporation Information
Table 156. Xian Janssen Description and Business Overview
Table 157. Xian Janssen Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Xian Janssen Anti-Peptic Ulcer Drugs Product
Table 159. Xian Janssen Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Anti-Peptic Ulcer Drugs Distributors List
Table 163. Anti-Peptic Ulcer Drugs Customers List
Table 164. Anti-Peptic Ulcer Drugs Market Trends
Table 165. Anti-Peptic Ulcer Drugs Market Drivers
Table 166. Anti-Peptic Ulcer Drugs Market Challenges
Table 167. Anti-Peptic Ulcer Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Product Picture
Figure 2. Global Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Gastritis Examples
Figure 7. Gastric Ulcers Examples
Figure 8. Duodenal Ulcers Examples
Figure 9. Gastroesophageal Reflux Disease (GERD) Examples
Figure 10. Global Anti-Peptic Ulcer Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anti-Peptic Ulcer Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Anti-Peptic Ulcer Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Anti-Peptic Ulcer Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Anti-Peptic Ulcer Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Anti-Peptic Ulcer Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Anti-Peptic Ulcer Drugs Players Market Share by Revenue in Anti-Peptic Ulcer Drugs: 2016 & 2020
Figure 29. Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Anti-Peptic Ulcer Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Anti-Peptic Ulcer Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 35. North America Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 36. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 37. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 38. China Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 39. China Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 40. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 41. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 44. India Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 45. India Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Anti-Peptic Ulcer Drugs
Figure 48. Manufacturing Process Analysis of Anti-Peptic Ulcer Drugs
Figure 49. Anti-Peptic Ulcer Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
抗潰瘍薬のグローバル市場調査 2019年 The global Anti-ulcer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti-ulcer Drug volume and value at global level, regional level and company level. From a global perspective, this report …- 世界の抗潰瘍薬市場規模・現状・予測（2021年-2027年） Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers. Some of the popularAntiulcerant Drugs currently in use are H2 receptor antagonists, gastric mucosal protective drugs, antacids and antibiotics. They can also be used as proton pump inhibitors in combination therap…
- 世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…
- 世界のブルーリ潰瘍治療市場規模・現状・予測（2021年-2027年） Buruli ulcer, caused by Mycobacterium ulcerans is an interminable devastating disorder that impacts basically the skin and bone now and then. Market Analysis and Insights: Global Buruli Ulcer Treatment Market The global Buruli Ulcer Treatment market size is projected to reach US$ XX million by 2027,…
- 世界の角膜潰瘍治療市場規模・現状・予測（2021年-2027年） The cornea is a transparent film in the front of the eyeball. It is often exposed to the air and has a high chance of coming into contact with germs. Corneal ulcers often occur due to foreign body trauma, traumatic injury after removal of corneal foreign body, trachoma and its complications, inversi…